Tumor collection and establishment of tumor-initiating cell cultures to serve as the antigen source for AV-OVA-1 dendritic cell vaccines for patients with newly diagnosed advanced ovarian cancer

ovapuldencel-T (AVOVA-1) - Lisata Therap, AiVita Biomedical

https://jitc.bmj.com/content/10/Suppl_2/A589

Ramez Eskander 1; Lisa Abaid 2; Bradley Corr 3; James Mason 4; Fabio Cappuccini 5; Richard Friedman 6; Rockelle Robles 7; Katrina Lopez 7; Gabriel Nistor 7; Robert Dillman 7

Oct 6, 2022